{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:45:10Z","timestamp":1790059510570,"version":"4.0.1"},"reference-count":35,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2014,9,24]],"date-time":"2014-09-24T00:00:00Z","timestamp":1411516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2015,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In recent years, major molecular remissions have been observed in patients with <jats:styled-content style=\"fixed-case\">JAK<\/jats:styled-content>2\u2010positive chronic myeloproliferative neoplasms (<jats:styled-content style=\"fixed-case\">MPN<\/jats:styled-content>s) after therapy with <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010<jats:italic>\u03b1<\/jats:italic>. <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010<jats:italic>\u03b1<\/jats:italic> is known to have altering effects on immune cells involved in immune surveillance and might consequently enhance anti\u2010tumor immune response against the <jats:styled-content style=\"fixed-case\">JAK<\/jats:styled-content>2\u2010mutated clone. The objective of this study was to investigate circulating levels and phenotype of natural killer cells in 29 <jats:styled-content style=\"fixed-case\">JAK<\/jats:styled-content>2\u2010positive <jats:styled-content style=\"fixed-case\">MPN<\/jats:styled-content> patients during <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010<jats:italic>\u03b1<\/jats:italic> treatment. Furthermore, functional studies of <jats:styled-content style=\"fixed-case\">NK<\/jats:styled-content> cells upon target\u2010cell recognition and cytokine stimulation were performed. The <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>56<jats:sup>bright<\/jats:sup> and <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>56<jats:sup>dim<\/jats:sup> <jats:styled-content style=\"fixed-case\">NK<\/jats:styled-content> cell subtypes display different properties in terms of cytokine production and cytotoxicity, respectively. Our results show a significant increase in the proportion of <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>56<jats:sup>bright<\/jats:sup> <jats:styled-content style=\"fixed-case\">NK<\/jats:styled-content> cells and a decreasing <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>56<jats:sup>dim<\/jats:sup> population during treatment with <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010<jats:italic>\u03b1<\/jats:italic> compared to patients that are untreated, treated with hydroxyurea and healthy controls, <jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.0001. Furthermore, an overall increase in cytokine\u2010dependent (<jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201012 and <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201015) <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010<jats:italic>\u03b3<\/jats:italic> expression by <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>56<jats:sup>dim<\/jats:sup> <jats:styled-content style=\"fixed-case\">NK<\/jats:styled-content> cells during <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010<jats:italic>\u03b1<\/jats:italic> treatment was observed. In contrast, our data indicate a compromised <jats:styled-content style=\"fixed-case\">NK<\/jats:styled-content> cell response to target\u2010cell recognition during treatment with <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010<jats:italic>\u03b1<\/jats:italic> in four patients. We also report low levels of circulating <jats:styled-content style=\"fixed-case\">NK<\/jats:styled-content> cells in untreated patients compared to healthy donors, patients treated with hydroxyurea and <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010<jats:italic>\u03b1<\/jats:italic>,<jats:italic> P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0.02. Based on our findings, one might speculate whether treatment with <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010<jats:italic>\u03b1<\/jats:italic> skews the human <jats:styled-content style=\"fixed-case\">NK<\/jats:styled-content> population toward a helper type that may assist in <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>8<jats:sup>+<\/jats:sup> T cell priming in lymphoid tissues at the expense of their immediate cytotoxic functions in peripheral blood and tissues.<\/jats:p>","DOI":"10.1111\/ejh.12420","type":"journal-article","created":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T07:47:20Z","timestamp":1406879240000},"page":"227-234","source":"Crossref","is-referenced-by-count":56,"title":["Expansion of circulating CD56<sup>bright<\/sup> natural killer cells in patients with JAK2\u2010positive chronic myeloproliferative neoplasms during treatment with interferon\u2010\u03b1"],"prefix":"10.1111","volume":"94","author":[{"given":"Caroline H.","family":"Riley","sequence":"first","affiliation":[{"name":"Department of Haematology Herlev Hospital University of Copenhagen Herlev Denmark"},{"name":"Center for Cancer Immune Therapy Herlev Hospital University of Copenhagen Herlev Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Hansen","sequence":"additional","affiliation":[{"name":"Center for Cancer Immune Therapy Herlev Hospital University of Copenhagen Herlev Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie K.","family":"Brimnes","sequence":"additional","affiliation":[{"name":"Institute of Inflammation Research Rigshospitalet University of Copenhagen Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans C.","family":"Hasselbalch","sequence":"additional","affiliation":[{"name":"Department of Haematology Roskilde Hospital University of Copenhagen Roskilde Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole W.","family":"Bjerrum","sequence":"additional","affiliation":[{"name":"Department of Haematology Rigshospitalet University of Copenhagen Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per thor","family":"Straten","sequence":"additional","affiliation":[{"name":"Center for Cancer Immune Therapy Herlev Hospital University of Copenhagen Herlev Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge Marie","family":"Svane","sequence":"additional","affiliation":[{"name":"Center for Cancer Immune Therapy Herlev Hospital University of Copenhagen Herlev Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Krogh","family":"Jensen","sequence":"additional","affiliation":[{"name":"Department of Haematology Herlev Hospital University of Copenhagen Herlev Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,9,24]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03546"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra063728"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.03.023"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051113"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-009860"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-143537"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1179\/102453309X12473408860587"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0498-4"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.6075"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-258772"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.2174\/138945011794815275"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-010-0993-2"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri1961"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2007.04.006"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-1114"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-09-077438"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(01)02060-9"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-238469"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1012356108"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.10.3146"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2008.03027.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.11.6477"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1154"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2003.10.012"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2876"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-340992"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2011.07.008"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI6218"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri1001"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200636290"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1138"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e318182de23"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3775"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxp029"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050128"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fejh.12420","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.12420","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T00:07:21Z","timestamp":1695514041000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.12420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,24]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["10.1111\/ejh.12420"],"URL":"https:\/\/doi.org\/10.1111\/ejh.12420","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,24]]}}}